Fertility and cancer - A new challenge in reproductive medicine?;Fertilität und krebs - Ein neues aufgabengebiet für die reproduktionsmedizin?

Journal fur Gynakologische Endokrinologie

Volumn 19, Issue 4, 2009, Pages 10-14

  Strowitzki, Thomas ^a   Germeyer, A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; FLUOROURACIL; GONADORELIN DERIVATIVE; METHOTREXATE; PREDNISOLONE; PREDNISONE; VINBLASTINE; VINCRISTINE; VINCRISTINE SULFATE;

CRYOPRESERVATION; DECISION MAKING; FEMALE; FEMALE FERTILITY; FEMALE INFERTILITY; HUMAN; NEOPLASM; OVARY DISEASE; PATIENT COUNSELING; PREMATURE OVARIAN FAILURE; REPRODUCTION; REVIEW; SURVIVAL TIME;

EID: 74049148104     PISSN: 19976690     EISSN: 19961553     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Linnet M, Ries LAG, Smith MA, Tarone RE, Devesa SS. Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst 1999; 91: 1051-8.
2. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1997; 47: 5-27.
3. Larsen EC, Muller J, Schmiegelow K, Rechnitzer C, Andersen AN. Reduced ovarian function in long-term survivors of radiation-and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab 2003; 88: 5307-14.
4. Haukvik UKH, Dieset I, Bjoro T, Holte H, Fossa SD. Treatment-related premature ovarian failure as a long-term complication after Hodgkin's lymphoma. Ann Oncol 2006; 17: 1428-33.
5. Brougham MF, Wallace WH. Subfertility in children and young people treated for solid and haematological malignancies. Br J Haematol 2005; 131: 143-55.
6. Bines J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 1996; 14: 1718-29.
7. Meirow D, Lewis H, Nugent D, Epstein M. Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: clinical importance and proposed accurate investigative tool. Hum Reprod 1999; 14: 1903-7.
8. Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, Oktay K; American Society of Clinical Oncology. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006; 24: 2917-31.
9. Petrek JA, Naughton MJ, Case LD, Paskett ED, Naftalis EZ, Singletary SE, Sukumvanich P. Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study. J Clin Oncol 2006; 24: 1045-51.
10. Rothenburg J, Strowitzki T, von Wolff M. Beurteilung der Ovarialtoxizität von Chemotherapien und dem ovarialprotektiven Effekt von GnRH-Analoga mit Hilfe von Inhibin B und Anti-Müller-Hormon. 56. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe, Geburtsh-Frauenheilkd 2006; 66: 125.
11. Ataya K, Rao LV, Lawrence E. Luteinizing hormone releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys. Biol Reprod 1995; 52: 365-2.
12. Blumenfeld Z, von Wolff M. GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy. Hum Reprod update 2008; 14: 543-52.
13. Chen C. Pregnancy after human oocyte cryopreservation. Lancet 1986; 1: 884-6.
14. Porcu E, Fabbri R, Maria Ciotti P, Frau F, De Cesare R, Venturosi S. Oocytes or embryo storage? Fertil Steril 2002; 78 (Suppl 1): 0-38.
15. Yang D, Winslow KL, Blohm PL, Brown SE, Nguyen K, Brubaker C. Oocyte donation using cryopreserved donor oocytes. Fertil Steril 2002; 78 (Suppl 1): 0-37.
16. Borini A, Bianchi V, Bonu MA, Sciajno R, Sereni E, Cattoli M, Mazzone S, Trevisi MR, Iadarola I, Distratis V, Nalon M, Coticchio G. Evidence-based clinical outcome of oocyte slow-freezing. Reprod Biomed Online 2007; 15: 175-81.
17. Hovatta O, Silye R, Krausz T, Abir R, Margara R, Trew G et al. Cryopreservation of human ovarian tissue using dimethylsulphoxide and propanediol-sucrose cryoprotectants. Hum Reprod 1996; 11: 1268-72.
18. Oktay K, Karlikaya G. Ovarian function after transplantation of frozen, banked autologous ovarian tissue. N Engl J Med 2000; 342: 1919.
19. Oktay K, Buyuk E, Veeck L, Zaninovic N, Xu K, Takeuchi T, Opsahl M, Rosenwaks Z. Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet 2004; 363: 837-40.
20. Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, Martinez-Madrid B, van Langendonckt A. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004; 364: 1405-10.
21. Demeestere I, Simon P, Buxant F, Robin V, Fernandez SA, Centner J, Delbaere A, Englert Y. Ovarian function and spontaneous pregnancy after combined heterotopic and orthotopic cryopreserved ovarian tissue transplantation in a patient previously treated with bone marrow transplantation: case report. Hum Reprod 2006; 21: 2010-4.
22. Oktay K, Hourvitz A, Sahin G, Oktem O, Safro B, Cil A, Bang H. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab 2006; 91: 3885-90.
23. Azim AA, Costantini-Ferrando M, Lostritto K, Oktay K. Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization. J Clin Endocrinol Metab 2007; 92: 2197-200.
24. von Wolff M, Thaler CJ, Frambach T, Zeeb C, Lawrenz B, Popovici RM, Strowitzki T. Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril 2008; 92: 1360-5.